Roivant Sciences

Roivant Sciences Ltd.
TypePublic
IndustryPharmaceuticals
FoundedApril 7, 2014 (2014-04-07)
FounderVivek Ramaswamy
Headquarters151 West 42nd Street
New York, NY 10036
U.S.
Key peopleMatt Gline (CEO)
RevenueIncrease US$125 million (2024)
Increase US$4.24 billion (2024)
Increase US$4.35 billion (2024)
Total assetsIncrease US$7.22 billion (2024)
Total equityIncrease US$6.45 billion (2024)
OwnerVivek Ramaswamy (10.5%)
Number of employees
908 (2024)
Websiteroivant.com
Footnotes
Financials as of 31 March 2024.

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.